{"id":"betamethasone-dipropionate-cream","safety":{"commonSideEffects":[{"rate":"null","effect":"Skin atrophy"},{"rate":"null","effect":"Hypersensitivity reactions"}]},"_chembl":{"chemblId":"CHEMBL3138708","moleculeType":"Small molecule","molecularWeight":"504.60"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by inhibiting the production of inflammatory mediators, such as prostaglandins and leukotrienes, which contribute to the symptoms of inflammation and itching. This results in a decrease in the number of immune cells, including eosinophils and lymphocytes, that contribute to the inflammatory response.","oneSentence":"Betamethasone dipropionate cream is a topical corticosteroid that reduces inflammation and itching by suppressing the immune system.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:22:58.281Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seborrheic dermatitis"},{"name":"Psoriasis"}]},"trialDetails":[{"nctId":"NCT07391423","phase":"NA","title":"Assessing Psoriasis Treatment Outcomes","status":"NOT_YET_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-04","conditions":"Psoriasis","enrollment":15},{"nctId":"NCT07357831","phase":"PHASE3","title":"A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects","status":"RECRUITING","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2025-12-26","conditions":"Plaque Psoriasis","enrollment":537},{"nctId":"NCT05981118","phase":"PHASE2, PHASE3","title":"Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant)","status":"ENROLLING_BY_INVITATION","sponsor":"Wake Forest University Health Sciences","startDate":"2024-07-15","conditions":"ICD10 Code L40.9 for Psoriasis","enrollment":40},{"nctId":"NCT05811234","phase":"","title":"A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in Adults","status":"COMPLETED","sponsor":"Almirall, S.A.","startDate":"2023-06-13","conditions":"Plaque Psoriasis","enrollment":291},{"nctId":"NCT06332612","phase":"PHASE1, PHASE2","title":"Metformin Repurposing in Oral Submucous Fibrosis: Unveiling In Vitro Signaling Pathways, Progressing to Clinical Trial","status":"COMPLETED","sponsor":"Ziauddin University","startDate":"2024-08-12","conditions":"Oral Submucous Fibrosis","enrollment":30},{"nctId":"NCT00875277","phase":"PHASE2","title":"A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2009-04","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT02376049","phase":"PHASE1","title":"A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-02","conditions":"Atopic Dermatitis","enrollment":30},{"nctId":"NCT00216892","phase":"PHASE4","title":"Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2005-04","conditions":"Psoriasis Vulgaris","enrollment":1032},{"nctId":"NCT01946386","phase":"PHASE1","title":"A Vasoconstriction Study With LEO 90100","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2013-09","conditions":"Psoriasis Vulgaris","enrollment":35},{"nctId":"NCT03308799","phase":"PHASE3","title":"A Clinical Trial Evaluating Efficacy and Safety of MC2-01 Cream","status":"COMPLETED","sponsor":"MC2 Therapeutics","startDate":"2017-10-03","conditions":"Psoriasis Vulgaris","enrollment":794},{"nctId":"NCT05882903","phase":"PHASE2","title":"The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis Post Functional Endoscopic Sinus Surgery (FESS)","status":"RECRUITING","sponsor":"Oticara Australia PTY LTD","startDate":"2023-08-17","conditions":"Chronic Rhinosinusitis (Diagnosis)","enrollment":24},{"nctId":"NCT05220293","phase":"PHASE1, PHASE2","title":"Treatment of Eosinophilic Chronic Rhinosinusitis Utilizing Betamethasone Dipropionate Nasal Cream","status":"TERMINATED","sponsor":"Oticara Australia PTY LTD","startDate":"2022-02-23","conditions":"Chronic Rhinosinusitis (Diagnosis)","enrollment":2},{"nctId":"NCT00820950","phase":"PHASE2","title":"A Study of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis","status":"COMPLETED","sponsor":"Incyte Corporation","startDate":"2007-05-31","conditions":"Psoriasis","enrollment":29},{"nctId":"NCT00800293","phase":"","title":"Randomized Study to Compare the Bioavailability of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2002-12","conditions":"Healthy","enrollment":116},{"nctId":"NCT02582177","phase":"PHASE3","title":"Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis","status":"COMPLETED","sponsor":"Ache Laboratorios Farmaceuticos S.A.","startDate":"2019-06-11","conditions":"Tinea","enrollment":125},{"nctId":"NCT04444726","phase":"NA","title":"Phototherpy Versus Tapwater Iontophoresis for Management of Atopic Dermatitis in Children.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-01-20","conditions":"Atopic Dermatitis","enrollment":60},{"nctId":"NCT03819218","phase":"PHASE2","title":"A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream in Adolescent Subjects","status":"TERMINATED","sponsor":"MC2 Therapeutics","startDate":"2018-12-27","conditions":"Psoriasis Vulgaris","enrollment":7},{"nctId":"NCT03802344","phase":"PHASE3","title":"This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 Cream","status":"COMPLETED","sponsor":"MC2 Therapeutics","startDate":"2018-12-12","conditions":"Psoriasis Vulgaris","enrollment":498},{"nctId":"NCT03766997","phase":"PHASE4","title":"Local Steroid Treatment for Idiopathic Granulomatous Mastitis (LSTIGM)","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2019-02-19","conditions":"Granulomatous Mastitis","enrollment":100},{"nctId":"NCT03899064","phase":"PHASE1","title":"Evaluation of Potential Development of Photoallergic Skin Reaction After Use of MC2-01 Cream","status":"COMPLETED","sponsor":"MC2 Therapeutics","startDate":"2019-02-13","conditions":"Photoallergy","enrollment":58},{"nctId":"NCT03892564","phase":"PHASE1","title":"Evaluation of Potential Phototoxicity Skin Reaction After Use of MC2-01 Cream","status":"COMPLETED","sponsor":"MC2 Therapeutics","startDate":"2019-02-27","conditions":"Phototoxicity","enrollment":35},{"nctId":"NCT03758365","phase":"PHASE1","title":"Evaluation of the Vasoconstriction Properties of MC2-01 Cream","status":"COMPLETED","sponsor":"MC2 Therapeutics","startDate":"2018-11-05","conditions":"Vasoconstriction","enrollment":36},{"nctId":"NCT03462927","phase":"PHASE2","title":"A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream","status":"COMPLETED","sponsor":"MC2 Therapeutics","startDate":"2018-02-08","conditions":"Psoriasis Vulgaris","enrollment":63},{"nctId":"NCT04071106","phase":"PHASE2, PHASE3","title":"Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical Trial","status":"UNKNOWN","sponsor":"Zagazig University","startDate":"2019-09-01","conditions":"Psoriasis","enrollment":50},{"nctId":"NCT02973776","phase":"PHASE1","title":"Vasoconstriction Trial With LEO 90100 Aerosol Foam","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2016-12","conditions":"Psoriasis Vulgaris","enrollment":36},{"nctId":"NCT02940002","phase":"PHASE1","title":"BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test","status":"COMPLETED","sponsor":"Bayer","startDate":"2016-10-12","conditions":"Psoriasis","enrollment":23}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":47,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Diprosone","Diprolene"],"phase":"phase_2","status":"active","brandName":"Betamethasone dipropionate cream","genericName":"Betamethasone dipropionate cream","companyName":"LEO Pharma","companyId":"leo-pharma","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Betamethasone dipropionate cream is a topical corticosteroid that reduces inflammation and itching by suppressing the immune system. Used for Seborrheic dermatitis, Psoriasis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}